TACROLIMUS XR SANDOZ tacrolimus (as monohydrate) 3 mg prolonged-release capsule blister pack

País: Austràlia

Idioma: anglès

Font: Department of Health (Therapeutic Goods Administration)

ingredients actius:

tacrolimus monohydrate, Quantity: 3.067 mg (Equivalent: tacrolimus, Qty 3 mg)

Disponible des:

Sandoz Pty Ltd

formulario farmacéutico:

Capsule, modified release

Composición:

Excipient Ingredients: ethylcellulose; hypromellose; lactose monohydrate; magnesium stearate; sunset yellow FCF; allura red AC; brilliant blue FCF; titanium dioxide; Gelatin; propylene glycol; butan-1-ol; sunset yellow FCF aluminium lake; isopropyl alcohol; brilliant blue FCF aluminium lake; allura red AC aluminium lake; lecithin; simethicone; ethanol; Shellac; strong ammonia solution; sulfuric acid

Vía de administración:

Oral

Unidades en paquete:

50, 60, 100, 30

tipo de receta:

(S4) Prescription Only Medicine

indicaciones terapéuticas:

TACROLIMUS XR SANDOZ are indicated for use as an adjunct to liver, kidney, lung or heart allograft transplantation in adults and children.

Resumen del producto:

Visual Identification: Capsules with light brown body and light orange cap imprinted in black with 3 mg; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Estat d'Autorització:

Registered

Data d'autorització:

2022-08-05